Cancer News

Grant supports identifying leukemia, Down syndrome linkYesterday
To better understand a predisposition for acute lymphoblastic leukemia in children with Down syndrome, a team of researchers will sequence the genomes of more than 2,000 individuals with Down syndrome.
Breakthrough reveals mutation driving acute myeloid leukemiaSep 10, 2018
Researchers have discovered that the growth of leukemic cells depends on mutant NPM1 gene and its abnormal transport out of the nucleus into the cytoplasm of the cell.
Study: HPV cancer survivors at risk for second HPV cancerSep 7, 2018
A retrospective study found that survivors of HPV-associated cancers have a high incidence of developing second HPV-related cancers.
‘Homing system’ targets therapeutic T cells to brain cancerSep 5, 2018
A multi-institution international team led by researchers at Baylor College of Medicine has developed a new strategy to overcome one of the main obstacles in the treatment of brain cancer – access to the tumor. 
Research leads to rare ER+ breast cancer mutations insightSep 4, 2018
Researchers conducted the largest analysis to date to establish associations between rare somatic mutations and prognosis in estrogen receptor positive (ER+) breast cancer
New histiocytotic disorder insights may improve therapiesAug 30, 2018
In a review published in New England Journal of Medicine, physician-scientists review the history of Langerhans-cell histiocytosis (LCH) and the recent developments that will help propel the treatment for patients into the realm of personalized medicine.
Non-alcoholic fatty liver disease a risk factor for liver cancerAug 27, 2018
To establish a better understanding of the link between the risk for liver cancer and non-alcoholic fatty liver disease (NAFLD), researchers conducted a large, retrospective study of patients with and without NAFLD.
Baylor awarded CPRIT Grants for research, recruitmentAug 27, 2018
Baylor College of Medicine has been awarded more than $31 million by the Cancer Prevention & Research Institute of Texas (CPRIT) to support new research, core facilities and recruitment of new faculty to support the fight against cancer.
Companies merge to implement Baylor College of Medicine-developed therapies for cancerAug 8, 2018
Researchers have developed a novel therapy for cancer patients that harnesses the patient’s own immune system to fight cancer in a natural way.
Altered gene regulation is more widespread in cancer than expected Jul 10, 2018
A team of researchers conducted a large-scale study that provides new insights into the mechanisms that can lead to cancer.